Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$10.7 - $17.48 $1,958 - $3,198
183 New
183 $3,000
Q4 2022

Feb 07, 2023

SELL
$4.53 - $7.55 $1,155 - $1,925
-255 Reduced 9.34%
2,475 $74,000
Q2 2022

Sep 06, 2022

BUY
$4.6 - $8.82 $12,557 - $24,078
2,730 New
2,730 $81,000
Q2 2022

Aug 12, 2022

SELL
$4.6 - $8.82 $12,557 - $24,078
-2,730 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$6.96 - $12.15 $19,000 - $33,169
2,730 New
2,730 $23,000
Q3 2021

Oct 06, 2021

SELL
$16.73 - $20.9 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$17.23 - $22.02 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$18.38 - $28.41 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$17.55 - $27.2 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$20.83 - $30.0 $0 - $0
0 New
0 $0

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $287M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.